Sabra Healthcare Reit (SBRA) has disclosed a new risk, in the Regulation category.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sabra Healthcare REIT has reported that there have been no material changes in their assessment of risk factors as outlined in their 2024 Annual Report on Form 10-K. This suggests that the company perceives its risk environment to be stable, with no new significant threats identified. Investors and stakeholders should consider this stability in risk assessment when evaluating the company’s future performance. However, it remains crucial to monitor any potential developments that could alter this risk landscape.
The average SBRA stock price target is $19.40, implying 6.71% upside potential.
To learn more about Sabra Healthcare Reit’s risk factors, click here.